LSVT Big and Dual Task Training in Cognitive Impaired Patients

August 18, 2025 updated by: Riphah International University

Effects of Lee Silverman Voice Treatment Big and Dual Task Training on Balance, Cognition and Functional Mobility in Older Adults With Cognitive Impairment.

The goal of this study ifs to determine the comparative effects of Lee Silverman voice treatment Big and dual task training on balance, cognition and functional mobility in older adults with cognitive impairment.

Perform LSVT big four times in a week for about 4 months. Perform dual task training four times in a week for about 4 months. Complete assessments at baseline, the 4th, 8th, 12th weeks, and a follow-up at the 16th week.

Outcome measures include Mini BESTest, MoCA, stroop test and time up and go test. Statistical analyses will assess within-group and between-group effects based on data distribution.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This study, titled "Effects of of lee Silverman voice treatment big and dual task training on balance, cognition and functional mobility in older adults with cognitive impairment" aims to assess the combined effectiveness of Lee Silverman voice treatment and dual task training in older adults with cognitive impairment.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Pakistan
    • Punjab
      • Lahore, Punjab, Pakistan, 54660
        • Recruiting
        • Iqra Medical Complex and Irtiqa Fitness Club
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Both male and female patients.
  • Age limit for patients will be above 65.
  • Patients with Mild and moderate cognitive impairment patients MoCA 13-25.
  • Patients with Berge balance scale value 41-50.
  • Patients who give consent to participate in study and undergo relevant test.

Exclusion Criteria:

  • Patients with any musculoskeletal disorder in which these exercises are contraindicated.
  • Patients using any walking aids.
  • Patients with hearing impairment.
  • Patients with other neurological conditions with limit the patient participation in planned exercise like stroke, Parkinson's.
  • Patients with diagnosed psychiatric disorder or taking medication that affect cognitive function within 24 hours.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A (LSVT BIG)
Group A will receive SLVT BIG intervention for 12 week (4 times per week) for 60 minutes
Other: Lee Silverman treatment big

Half of the treatment sessions consist of standardized multidirectional whole-body movements performed with maximal amplitude of reaching and stepping. The second half is designed to address individual deficits in movement that occur in activities of daily living.

Dosage: 4 consecutive days a week for 12 weeks (16 sessions in one month) for 60 minutes Repetitions: minimum 8-16 repetitions/task
Experimental: Group B ( Dual task training)
Group B will receive cognitive motor dual task training for 12 weeks (4 times per week) for 60 minutes.
Other: Dual task training
Group B will receive cognitive motor dual task training for 60 minutes, 4 times a week for 12 weeks. The intervention include both motor and cognitive components.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mini BESTest
Time Frame: 4th week
It is a short form of the BESTest which include 14 items only. The Mini-BESTest includes asses aspects of dynamic balance control also and control while walking and performing a cognitive task.
4th week
MoCA (Montreal Cognitive Assessment (For Cognition)
Time Frame: 4th week
The Montreal Cognitive Assessment (MoCA) is cognitive screening tool which include 30 points. It measures visuospatial, short term memory, orientation, language, executive functioning along with attention/concentration/working memory.
4th week
Stroop test
Time Frame: 4th week
The Stroop task is one of the most widely used measures of cognitive functioning. The Stroop test requires participants to name the color in which a presented word is printed. Numerous studies have shown that participants need more time to name ink colors of incongruent words than to name ink colors of control patches.
4th week
Time up and go test
Time Frame: 4th week
Timed Up and Go (TUG) have been used in clinical settings as a measure of physical performance in older adults with and without cognitive dysfunction. This test requires people to stand up from a chair, walk 3 m, turn around, walk back to the chair, and sit down again.
4th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Riphah International University

Investigators

  • Principal Investigator: Arooba Saeed, phD, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 10, 2025

Primary Completion (Estimated)

October 30, 2025

Study Completion (Estimated)

October 30, 2025

Study Registration Dates

First Submitted

April 7, 2025

First Submitted That Met QC Criteria

April 7, 2025

First Posted (Actual)

April 15, 2025

Study Record Updates

Last Update Posted (Actual)

August 22, 2025

Last Update Submitted That Met QC Criteria

August 18, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/0258 Rabia Aslam

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Impairment

Clinical Trials on Lee Silverman treatment big

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe